المؤلفون: Akhtar, Zubair, Götberg, Matthias, Erlinge, David, Christiansen, Evald H., Oldroyd, Keith G., Motovska, Zuzana, Erglis, Andrejs, Hlinomaz, Ota, Jakobsen, Lars, Engstrøm, Thomas, Jensen, Lisette O., Fallesen, Christian O., Jensen, Svend E., Angerås, Oskar, Calais, Fredrik, Kåregren, Amra, Lauermann, Jörg, Mokhtari, Arash, Nilsson, Johan, Persson, Jonas, Islam, Abu K.M.M., Rahman, Afzalur, Malik, Fazila, Choudhury, Sohel, Collier, Timothy, Pocock, Stuart J., Pernow, John, MacIntyre, Chandini R., Fröbert, Ole

المصدر: Vaccine. 41(48):7159-7165

مصطلحات موضوعية: Influenza vaccination, Myocardial infarction, Optimal timing, Percutaneous coronary intervention, Vaccine effectiveness

وصف الملف: electronic

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-217339Test
https://doi.org/10.1016Test/j.vaccine.2023.10.028
https://umu.diva-portal.org/smash/get/diva2:1816752/FULLTEXT01.pdfTest

المؤلفون: Fröbert, Ole, 1964, Götberg, Matthias, Erlinge, David, Akhtar, Zubair, Christiansen, Evald H., MacIntyre, Chandini R., Oldroyd, Keith G., Motovska, Zuzana, Erglis, Andrejs, Moer, Rasmus, Hlinomaz, Ota, Jakobsen, Lars, Engstrøm, Thomas, Jensen, Lisette O., Fallesen, Christian O., Jensen, Svend E., Angerås, Oskar, Calais, Fredrik, 1971, Kåregren, Amra, Lauermann, Jörg, Mokhtari, Arash, Nilsson, Johan, Persson, Jonas, Stalby, Per, Islam, Abu K. M. M., Rahman, Afzalur, Malik, Fazila, Choudhury, Sohel, Collier, Timothy, Pocock, Stuart J., Pernow, John

المصدر: American Heart Journal. 255:82-89

مصطلحات موضوعية: Influenza vaccination, Myocardial infarction, Percutaneous coronary intervention

وصف الملف: electronic

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-101909Test
https://oru.diva-portal.org/smash/get/diva2:1706042/FULLTEXT01.pdfTest

المؤلفون: Gregson, John, Stone, Gregg W, Bhatt, Deepak L, Packer, Milton, Anker, Stefan D, Zeller, Cordula, Redfors, Björn, Pocock, Stuart J

المساهمون: Göteborgs universitet, Sahlgrenska akademin, Institutionen för medicin, avdelningen för molekylär och klinisk medicin, Gothenburg University, Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine

المصدر: Journal of the American College of Cardiology. 82(14):1445-1463

مصطلحات موضوعية: Kardiologi, Cardiac and Cardiovascular Systems

الوصول الحر: https://gup.ub.gu.se/publication/329192Test

المؤلفون: Wussler, Desiree, Belkin, Maria, Shrestha, Samyut, Wernicke, Hannah, Papachristou, Androniki, Nowak, Albina, Aliyeva, Fatima, Mork, Constantin, Strebel, Ivo, Huré, Gabrielle Valerie Francoi, Weil, Dominic, Michou, Eleni, Kozhuharov, Nikola, Gualandro, Danielle M., Puelacher, Christian, Miró, Oscar, Rossello, Xavier, Martín‐Sánchez, Francisco Javier, Pocock, Stuart J., Goudev, Assen, Breidthardt, Tobias, Mueller, Christian

المساهمون: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Schweizerische Herzstiftung

المصدر: European Journal of Heart Failure ; ISSN 1388-9842 1879-0844

الإتاحة: https://doi.org/10.1002/ejhf.3349Test

المؤلفون: Sattar, Naveed, Butler, Javed, Lee, Matthew M.Y., Harrington, Josephine, Sharma, Abhinav, Zannad, Faiez, Filippatos, Gerasimos, Verma, Subodh, Januzzi, James, L, Ferreira, João Pedro, Pocock, Stuart, J, Pfarr, Egon, Ofstad, Anne, P, Brueckmann, Martina, Packer, Milton, Anker, Stefan, D

المساهمون: University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow & Clyde Glasgow (NHSGGC), Baylor Scott and White Research Institute Dallas, TX, USA, University of Mississippi Medical Center (UMMC), Duke University Durham, DREAM-CV Lab, McGill University = Université McGill Montréal, Canada, McGill University Health Center Montreal (MUHC), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, St. Michael's Hospital, University of Toronto, Massachusetts General Hospital Boston, Baim Institute for Clinical Research Boston MA, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Centro Hospitalar Vila Nova de Gaia/Espinho, London School of Hygiene and Tropical Medicine (LSHTM), Boehringer Ingelheim International GmbH, Boehringer Ingelheim Norway KS, Oslo Diabetes Research Center, Universität Heidelberg Heidelberg = Heidelberg University, Baylor College of Medicine (BCM), Baylor University, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Wrocław Medical University, Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité Campus Virchow-Klinikum (CVK), The EMPEROR-Preserved trial (ClinicalTrials.gov: NCT03057951) was funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04529502Test ; European Journal of Heart Failure, 2024, ⟨10.1002/ejhf.3221⟩.

مصطلحات موضوعية: Kidney disease • SGLT2 inhibitor, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38558521; hal-04529502; https://hal.univ-lorraine.fr/hal-04529502Test; https://hal.univ-lorraine.fr/hal-04529502/documentTest; https://hal.univ-lorraine.fr/hal-04529502/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Sattar%20-%20Body%20mass%20index%20and%20cardiorenal%20outcomes%20in%20the%20EMPEROR%E2%80%90Preserved%20trial%20.pdfTest; PUBMED: 38558521

الإتاحة: https://doi.org/10.1002/ejhf.3221Test
https://hal.univ-lorraine.fr/hal-04529502Test
https://hal.univ-lorraine.fr/hal-04529502/documentTest
https://hal.univ-lorraine.fr/hal-04529502/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Sattar%20-%20Body%20mass%20index%20and%20cardiorenal%20outcomes%20in%20the%20EMPEROR%E2%80%90Preserved%20trial%20.pdfTest

المؤلفون: Dhingra, Nitish, K, Verma, Subodh, Butler, Javed, Anker, Stefan, D, Ferreira, Joao Pedro, Filippatos, Gerasimos, Januzzi, James, L, Lam, Carolyn S.P., Sattar, Naveed, Zaremba-Pechmann, Liliana, Böhm, Michael, Nordaby, Matias, Brueckmann, Martina, Pocock, Stuart, J, Zannad, Faiez, Packer, Milton

المساهمون: St. Michael's Hospital, University of Toronto, Baylor Scott & White Research Institute (BSWRI), University of Mississippi Medical Center (UMMC), German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Cardiovascular Research and Development Center (UnIC@RISE), National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, Massachusetts General Hospital Boston, Harvard Medical School Boston (HMS), National Heart Centre Singapore (NHCS), Duke-NUS Medical School Singapore, University of Glasgow, Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Boehringer Ingelheim International GmbH, Universität Heidelberg Heidelberg = Heidelberg University, London School of Hygiene and Tropical Medicine (LSHTM), Baylor University Medical Center, Baylor College of Medecine, Imperial College London

المصدر: ISSN: 2213-1779.

مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37715769; hal-04384319; https://hal.univ-lorraine.fr/hal-04384319Test; https://hal.univ-lorraine.fr/hal-04384319/documentTest; https://hal.univ-lorraine.fr/hal-04384319/file/1-s2.0-S2213177923004535-main.pdfTest; PUBMED: 37715769

الإتاحة: https://doi.org/10.1016Test/j.jchf.2023.06.036
https://hal.univ-lorraine.fr/hal-04384319Test
https://hal.univ-lorraine.fr/hal-04384319/documentTest
https://hal.univ-lorraine.fr/hal-04384319/file/1-s2.0-S2213177923004535-main.pdfTest

المؤلفون: Rastogi, Tripti, Ferreira, João Pedro, Butler, Javed, Kraus, Bettina Johanna, Mattheus, Michaela, Brueckmann, Martina, Filippatos, Gerasimos, Wanner, Christoph, Pocock, Stuart, J, Packer, Milton, Anker, Stefan, D, Zannad, Faiez

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Baylor Scott & White Research Institute (BSWRI), University of Mississippi Medical Center (UMMC), Julius-Maximilians-Universität Würzburg (JMU), Boehringer Ingelheim International GmbH, University Hospital Wuerzburg / Universitäts­klinikum Würzburg, Boehringer Ingelheim Pharma GmbH & Co. KG, Universität Heidelberg Heidelberg = Heidelberg University, National and Kapodistrian University of Athens (NKUA), “Attikon” University Hospital, London School of Hygiene and Tropical Medicine (LSHTM), Baylor University Medical Center, Baylor College of Medecine, Imperial College London, Berlin-Brandenburg Center for Regenerative Medicine Berlin, Germany (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital Berlin, German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), The EMPEROR-Preserved trial was funded by Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance

المصدر: ISSN: 1388-9842 ; European Journal of Heart Failure ; https://hal.univ-lorraine.fr/hal-04427009Test ; European Journal of Heart Failure, 2024, ⟨10.1002/ejhf.3136⟩.

مصطلحات موضوعية: Estimated glomerular filtration rate changes Heart failure with preserved ejection fraction Empagliflozin Cardiovascular and renal outcomes, Estimated glomerular filtration rate changes, Heart failure with preserved ejection fraction, Empagliflozin, Cardiovascular and renal outcomes, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38247160; hal-04427009; https://hal.univ-lorraine.fr/hal-04427009Test; https://hal.univ-lorraine.fr/hal-04427009/documentTest; https://hal.univ-lorraine.fr/hal-04427009/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Rastogi%20-%20Early%20changes%20in%20estimated%20glomerular%20filtration%20rate%20post%E2%80%90initiation%20of.pdfTest; PUBMED: 38247160

الإتاحة: https://doi.org/10.1002/ejhf.3136Test
https://hal.univ-lorraine.fr/hal-04427009Test
https://hal.univ-lorraine.fr/hal-04427009/documentTest
https://hal.univ-lorraine.fr/hal-04427009/file/European%20J%20of%20Heart%20Fail%20-%202024%20-%20Rastogi%20-%20Early%20changes%20in%20estimated%20glomerular%20filtration%20rate%20post%E2%80%90initiation%20of.pdfTest

المؤلفون: Pocock, Stuart J., Owen, Ruth, Gregson, John, Mt-Isa, Shahrul, Baumgartner, Richard, Ashby, Deborah, Stone, Gregg W.

المساهمون: Merck & Co Inc

المصدر: Journal of Thrombosis and Haemostasis ; ISSN 1538-7836

مصطلحات موضوعية: Hematology

الإتاحة: https://doi.org/10.1016Test/j.jtha.2024.01.012
https://api.elsevier.com/content/article/PII:S1538783624000503?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1538783624000503?httpAccept=text/plainTest

المؤلفون: Fröbert, Ole, 1964, Götberg, Matthias, Erlinge, David, Akhtar, Zubair, Christiansen, Evald H., MacIntyre, Chandini R., Oldroyd, Keith G., Motovska, Zuzana, Erglis, Andrejs, Moer, Rasmus, Hlinomaz, Ota, Jakobsen, Lars, Engstrøm, Thomas, Jensen, Lisette O., Fallesen, Christian O., Jensen, Svend E., Angerås, Oskar, Calais, Fredrik, 1971, Kåregren, Amra, Lauermann, Jörg, Mokhtari, Arash, Nilsson, Johan, Persson, Jonas, Stalby, Per, Islam, Abu K. M. M., Rahman, Afzalur, Malik, Fazila, Choudhury, Sohel, Collier, Timothy, Pocock, Stuart J., Pernow, John

المصدر: Circulation. 144(18):1476-1484

مصطلحات موضوعية: influenza vaccines, myocardial infarction, randomized controlled trial

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-93974Test
https://doi.org/10.1161/CIRCULATIONAHA.121.057042Test

المؤلفون: Anker, Stefan D, Butler, Javed, Khan, Muhammad Shahzeb, Abraham, William T, Bauersachs, Johann, Bocchi, Edimar, Bozkurt, Biykem, Braunwald, Eugene, Chopra, Vijay K, Cleland, John G, Ezekowitz, Justin, Filippatos, Gerasimos, Friede, Tim, Hernandez, Adrian F, Lam, Carolyn SP, Lindenfeld, JoAnn, McMurray, John JV, Mehra, Mandeep, Metra, Marco, Packer, Milton, Pieske, Burkert, Pocock, Stuart J, Ponikowski, Piotr, Rosano, Giuseppe MC, Teerlink, John R, Tsutsui, Hiroyuki, Van Veldhuisen, Dirk J, Verma, Subodh, Voors, Adriaan A, Wittes, Janet, Zannad, Faiez, Zhang, Jian, Seferovic, Petar, Coats, Andrew JS

المصدر: European Heart Journal. 41(22)

مصطلحات موضوعية: Clinical Research, Patient Safety, Clinical Trials and Supportive Activities, Cardiovascular, Heart Disease, Prevention, Good Health and Well Being, Betacoronavirus, COVID-19, Clinical Trials as Topic, Coronavirus Infections, Europe, Heart Failure, Humans, Informed Consent, Pandemics, Patient Selection, Pneumonia, Viral, Research Design, SARS-CoV-2, Heart failure, Clinical trials, Coronavirus, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Cardiovascular System & Hematology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/3qc568txTest